Arvinas, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ARVN on Nasdaq
Location
395 Winchester Ave, 5 Science Park, New Haven, CT

Insiders trading volume in the past year

Arvinas, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Timothy M. Shannon Director $27.9M Jun 16, 2022
John G. Houston President and CEO, Director $22.9M -$524K -2.24% Feb 24, 2025
Sean A. Cassidy Chief Financial Officer $8.56M Feb 23, 2024
Ronald Peck Chief Medical Officer $4.11M Feb 23, 2024
Ian Taylor President, R&D $3.14M -$151K -4.59% Feb 24, 2025
Liam Ratcliffe Director $3.13M Jun 16, 2022
Randy Teel Int. Chief Financial Officer $3.11M May 21, 2024
Noah Berkowitz Chief Medical Officer $2.53M -$74.4K -2.86% May 9, 2025
Andrew Saik Chief Financial Officer $2.45M -$43.4K -1.74% Jun 24, 2025
Angela M. Cacace Chief Scientific Officer $2.35M -$89.6K -3.67% Jun 17, 2025
Bradley Margus Director $1.15M Jun 16, 2022
Edward Moore Kennedy Jr. Director $807K Jun 25, 2025
Briggs Morrison Director $720K +$227K +46% Sep 22, 2025
David K. Loomis Chief Accounting Officer $572K -$22.6K -3.8% Nov 7, 2025
Sunil Agarwal Director $435K Jun 25, 2025
Everett Cunningham Director $396K Jun 25, 2025
Laurie Smaldone Director $396K Jun 25, 2025
Leslie V. Norwalk Director $396K Jun 25, 2025
John Young Director $396K Jun 25, 2025
Linda Bain Director $396K Jun 25, 2025
Wendy L. Dixon Director $351K Jun 15, 2023

Recent Insider Transactions by Companies or Individuals for Arvinas, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.